ArcBest beat fourth-quarter expectations Friday but noted that continued industrial weakness is weighing on its results.

Novartis was among the most prolific pharma dealmakers in 2024, a trend that it expects to continue with more bolt-on deals this year to set up for sustainable long-term growth.

Q4 2024 Earnings Call Transcript January 29, 2025 Navient Corporation misses on earnings expectations. Reported EPS is $0.25 ...

Elon Musk claimed this week that Tesla robotaxi's will hit the roads this summer however skepticism from industry experts and ...

Welcome to the SiriusXM fourth-quarter and full-year 2024 operating and financial results conference call. [Operator ...

Q4 2024 Earnings Conference Call January 30, 2025 5:00 PM ETCompany ParticipantsCam Carey - Head of Investor RelationsAndrew Ng ...

Q4 2024 Earnings Conference Call January 30, 2025 5:00 PM ETCompany ParticipantsJohn Pitzer - Corporate Vice President ...

The credit card issuer's earnings missed Wall Street estimates, but it reported improvement in sales, delinquencies and ...

Apple reported $18.5 billion in sales in greater China last quarter, comfortably below consensus estimates of $20.9 billion.

Meta CEO Mark Zuckerberg teased a "return to OG Facebook" as part of his key goals for 2025 in Wednesday's Q4 earnings call ...

The other tidbit that seems to have investors very excited is Musk’s promise that the company’s Cybercab Robotaxi, which we ...

The Stamford, Conn.-based company posted a 1.5% increase in Q4 net income to $689 million from $679 million. Revenue ...